Rita Schoeny

7.9k total citations · 2 hit papers
74 papers, 6.1k citations indexed

About

Rita Schoeny is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Plant Science. According to data from OpenAlex, Rita Schoeny has authored 74 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Health, Toxicology and Mutagenesis, 38 papers in Cancer Research and 14 papers in Plant Science. Recurrent topics in Rita Schoeny's work include Carcinogens and Genotoxicity Assessment (38 papers), Toxic Organic Pollutants Impact (21 papers) and Effects and risks of endocrine disrupting chemicals (21 papers). Rita Schoeny is often cited by papers focused on Carcinogens and Genotoxicity Assessment (38 papers), Toxic Organic Pollutants Impact (21 papers) and Effects and risks of endocrine disrupting chemicals (21 papers). Rita Schoeny collaborates with scholars based in United States, United Kingdom and Canada. Rita Schoeny's co-authors include David M. DeMarini, Susan D. Richardson, Michael J. Plewa, Elizabeth D. Wagner, Emily Oken, Anna L. Choi, Mary K. Manibusan, Susan Korrick, Margaret R. Karagas and Philippe Grandjean and has published in prestigious journals such as American Journal of Public Health, Environmental Health Perspectives and Chemosphere.

In The Last Decade

Rita Schoeny

72 papers receiving 5.9k citations

Hit Papers

Occurrence, genotoxicity, and carcinogenicity of regulate... 2007 2026 2013 2019 2007 2012 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rita Schoeny United States 30 4.4k 907 816 766 765 74 6.1k
Terttu Vartiainen Finland 53 5.1k 1.2× 1.1k 1.3× 894 1.1× 1.3k 1.7× 687 0.9× 190 7.6k
Kenneth P. Cantor United States 54 3.7k 0.8× 1.3k 1.5× 797 1.0× 611 0.8× 1.0k 1.3× 141 8.2k
Cristina M. Villanueva Spain 36 3.9k 0.9× 222 0.2× 1.2k 1.5× 533 0.7× 999 1.3× 117 6.1k
David M. DeMarini United States 48 5.7k 1.3× 2.7k 2.9× 981 1.2× 1.4k 1.9× 1.2k 1.5× 201 10.0k
Yunhui Zhang China 48 3.7k 0.8× 204 0.2× 648 0.8× 1.1k 1.5× 313 0.4× 230 7.2k
Zhiqiang Yu China 49 4.7k 1.1× 497 0.5× 828 1.0× 2.8k 3.7× 619 0.8× 276 8.2k
Jane Ellen Simmons United States 30 2.1k 0.5× 342 0.4× 428 0.5× 418 0.5× 607 0.8× 90 2.9k
Des Connell Australia 46 4.5k 1.0× 265 0.3× 544 0.7× 2.6k 3.4× 747 1.0× 219 9.0k
Karl‐Werner Schramm Germany 47 5.6k 1.3× 578 0.6× 420 0.5× 2.3k 3.0× 860 1.1× 343 8.3k
Clément G. Yedjou United States 27 3.0k 0.7× 341 0.4× 960 1.2× 2.3k 3.0× 429 0.6× 64 7.6k

Countries citing papers authored by Rita Schoeny

Since Specialization
Citations

This map shows the geographic impact of Rita Schoeny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Schoeny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Schoeny more than expected).

Fields of papers citing papers by Rita Schoeny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Schoeny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Schoeny. The network helps show where Rita Schoeny may publish in the future.

Co-authorship network of co-authors of Rita Schoeny

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Schoeny. A scholar is included among the top collaborators of Rita Schoeny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Schoeny. Rita Schoeny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Samuel M., Alan R. Boobis, David Jacobson‐Kram, et al.. (2025). Mode of action approach supports a lack of carcinogenic potential of six organic UV filters. Critical Reviews in Toxicology. 55(2). 248–284. 3 indexed citations
2.
Kozal, Jordan S., Heather N. Lynch, Joanna Klapacz, et al.. (2023). Mode of action assessment for propylene dichloride as a human carcinogen. Chemico-Biological Interactions. 382. 110382–110382. 3 indexed citations
3.
Bates, Christopher A., Lynne T. Haber, Martha M. Moore, Rita Schoeny, & Andrew Maier. (2023). Development of a framework for risk assessment of dietary carcinogens. Food and Chemical Toxicology. 180. 114022–114022. 1 indexed citations
4.
Lynch, Heather N., Jordan S. Kozal, Melissa Vincent, et al.. (2023). Systematic review of the human health hazards of propylene dichloride. Regulatory Toxicology and Pharmacology. 144. 105468–105468. 2 indexed citations
5.
Anderson, Janet K., Ian T. Cousins, Jamie C. DeWitt, et al.. (2022). Grouping of PFAS for human health risk assessment: Findings from an independent panel of experts. Regulatory Toxicology and Pharmacology. 134. 105226–105226. 28 indexed citations
6.
Haber, Lynne T., Rita Schoeny, & Bruce C. Allen. (2021). Impact of updated BMD modeling methods on perchlorate and chlorate assessments of human health hazard. Toxicology Letters. 340. 89–100. 4 indexed citations
7.
Schoeny, Rita, Kevin P. Cross, David M. DeMarini, et al.. (2020). Revisiting the bacterial mutagenicity assays: Report by a workgroup of the International Workshops on Genotoxicity Testing (IWGT). Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 849. 503137–503137. 6 indexed citations
8.
Cohen, Samuel M., Alan R. Boobis, Vicki L. Dellarco, et al.. (2019). Chemical carcinogenicity revisited 3: Risk assessment of carcinogenic potential based on the current state of knowledge of carcinogenesis in humans. Regulatory Toxicology and Pharmacology. 103. 100–105. 71 indexed citations
9.
Wolf, Douglas C., Samuel M. Cohen, Alan R. Boobis, et al.. (2019). Chemical carcinogenicity revisited 1: A unified theory of carcinogenicity based on contemporary knowledge. Regulatory Toxicology and Pharmacology. 103. 86–92. 59 indexed citations
10.
Doe, John E., Alan R. Boobis, Vicki L. Dellarco, et al.. (2019). Chemical carcinogenicity revisited 2: Current knowledge of carcinogenesis shows that categorization as a carcinogen or non-carcinogen is not scientifically credible. Regulatory Toxicology and Pharmacology. 103. 124–129. 45 indexed citations
11.
Martus, Hans‐Joerg, Makoto Hayashi, Masamitsu Honma, et al.. (2015). Summary of major conclusions from the 6th International Workshop on Genotoxicity Testing (IWGT), Foz do Iguaçu, Brazil. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 783. 1–5. 6 indexed citations
12.
Aylward, Lesa L., Santhini Ramasamy, Sean M. Hays, Rita Schoeny, & Christopher R. Kirman. (2014). Evaluation of urinary speciated arsenic in NHANES: Issues in interpretation in the context of potential inorganic arsenic exposure. Regulatory Toxicology and Pharmacology. 69(1). 49–54. 46 indexed citations
13.
Pottenger, Lynn H., Larry S. Andrews, Ammie N. Bachman, et al.. (2014). An organizational approach for the assessment of DNA adduct data in risk assessment: case studies for aflatoxin B1, tamoxifen and vinyl chloride. Critical Reviews in Toxicology. 44(4). 348–391. 22 indexed citations
14.
Karagas, Margaret R., Anna L. Choi, Emily Oken, et al.. (2012). Evidence on the Human Health Effects of Low-Level Methylmercury Exposure. Environmental Health Perspectives. 120(6). 799–806. 501 indexed citations breakdown →
15.
Moore, Martha M., Masamitsu Honma, Julie Clements, et al.. (2011). Suitable top concentration for tests with mammalian cells: Mouse lymphoma assay workgroup. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 723(2). 84–86. 13 indexed citations
16.
Jarabek, Annie M., Lynn H. Pottenger, Larry S. Andrews, et al.. (2009). Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization. Critical Reviews in Toxicology. 39(8). 659–678. 76 indexed citations
17.
Rice, Glenn, Jeff Swartout, Kathryn R. Mahaffey, & Rita Schoeny. (2000). DERIVATION OF U.S. EPA'S ORAL REFERENCE DOSE (RFD) FOR METHYLMERCURY. Drug and Chemical Toxicology. 23(1). 41–54. 94 indexed citations
18.
Schoeny, Rita. (1996). Use of genetic toxicology data in U.S. EPA risk assessment: the mercury study report as an example.. Environmental Health Perspectives. 104(suppl 3). 663–673. 32 indexed citations
19.
Valanis, Barbara, et al.. (1994). Urinary biological monitoring markers of anticancer drug exposure in oncology nurses.. American Journal of Public Health. 84(5). 852–855. 12 indexed citations
20.
Stiteler, William, et al.. (1993). A Statistical Test of Compatibility of Data Sets to a Common Dose-Response Model. Regulatory Toxicology and Pharmacology. 18(3). 392–402. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026